Essel Pharmaceuticals Private Limited, a active private limited company, was established on 04 November 1991 in Kanpur, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239UP1991PTC013679. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.88 M.
It upholds a compliant status. Its leadership includes Parmod Kumar Lohia (Director), Indu Saraf (Director), Ramesh Kumar Saraf (Director). Past directors included Balkishan Gupta. It holds ₹3.28 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 8, Block A, Hall B, Ispat Nagar, Kanpur, Uttar Pradesh, 208020.
U24239UP1991PTC013679
013679
04 November 1991
₹1.00 M
₹0.88 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Essel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parmod Kumar Lohia | Director | 04 Nov 1991 | Current |
| Indu Saraf | Director | 04 Nov 1991 | Current |
| Ramesh Kumar Saraf | Director | 04 Nov 1991 | Current |
| Mitesh Saraf | Director | 30 Mar 2015 | Current |
| Khushboo Saraf | Director | 30 Mar 2015 | Current |
| Manju Lohia | Director | 04 Nov 1991 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Essel Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.65% increase. The company also saw a substantial fall in profitability, with a 21.74% decrease in profit. The company's net worth moved up by a moderate rise of 3.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Essel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹32,804,598.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2024 | Others | ₹1.50 M | Open |
| 09 Jul 2024 | Others | ₹3.03 Cr | Open |
| 21 Jan 2022 | Hdfc Bank Limited | ₹0.50 M | Open |
| 02 Jul 2021 | Hdfc Bank Limited | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Essel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Essel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Essel Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 30.30 M registered on 09 Jul 2024 with Charge ID 100951193 was modified on 23 Jun 2025. was documented.
Progress on Essel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others amounted to Rs. 1.50 M with Charge ID 100967324 was registered on 28 Aug 2024. was documented.
Progress on A charge with Others amounted to Rs. 30.30 M with Charge ID 100951193 was registered on 09 Jul 2024. was documented.
Progress on Essel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.50 M with Charge ID 100544814 was registered on 21 Jan 2022. was documented.
The CIN of Essel Pharmaceuticals Private Limited is U24239UP1991PTC013679.
Essel Pharmaceuticals Private Limited is headquartered at Plot No. 8, Block A, Hall B, Ispat Nagar, Kanpur, Uttar Pradesh, 208020.
Essel Pharmaceuticals Private Limited was incorporated on 04 November 1991.
The current directors of Essel Pharmaceuticals Private Limited are
The primary industry of Essel Pharmaceuticals Private Limited is Trade.
Essel Pharmaceuticals Private Limited is unlisted.
The authorized capital of Essel Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.88 M.
The compliance status of Essel Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX